# Peptides for Fertility: Egg & Sperm Evidence Ranked (2026)

> The honest fertility-peptide record: the strongest evidence belongs to the prescription reproductive hormones already in every IVF clinic — hCG, gonadotropins, gonadorelin — plus one investigational frontier, kisspeptin. No over-the-counter research peptide has human fertility data.

*Published 2026-07-01 · Updated 2026-07-01 · By Elena Soto, PharmD*

The short answer
For fertility, the peptides with the strongest evidence are the ones already sitting in every IVF clinic's fridge: **human chorionic gonadotropin (hCG), the gonadotropins (FSH and LH), and pulsatile gonadorelin** — decades-old, FDA-approved, RCT- and meta-analysis-backed reproductive hormones, not biohacker compounds.[8](https://peptidevox.com/#r8)[13](https://peptidevox.com/#r13) The one genuinely novel research peptide with human fertility data is **kisspeptin**, an investigational IVF trigger.[1](https://peptidevox.com/#r1) There is **no over-the-counter research peptide with human evidence** for treating infertility.[7](https://peptidevox.com/#r7)

*This article is informational and editorial content for research and educational purposes only. It is not medical advice, not a protocol to follow, and not a sourcing or buying guide. Infertility is a medical diagnosis with many root causes and deserves a full work-up by a reproductive endocrinologist or urologist — not a peptide bought online. The most evidence-based fertility peptides are prescription hormones administered under specialist supervision inside monitored protocols. Dosing figures, where mentioned, are reported strictly as they appear in published literature and regulatory labeling, for completeness only. Consult a licensed clinician who knows your history before any decision.*

## Which peptides actually have fertility evidence?

The honest bottom line is unusual for a peptide article: the “fertility peptides” that actually move egg and sperm endpoints are the **glycoprotein and peptide hormones of the reproductive axis**. hCG, the gonadotropins (FSH and LH, as recombinant or urinary/menopausal preparations), and gonadorelin (synthetic GnRH) earn **Grade A-B** evidence because they directly replace the hormonal signals that drive ovulation and spermatogenesis.[8](https://peptidevox.com/#r8)[21](https://peptidevox.com/#r21) They are not marketed as biohacker peptides, but pharmacologically that is exactly what they are.

The genuinely novel research peptide in this space is **kisspeptin** (KP-54 / KP-10), which sits one step upstream of GnRH. It has the most interesting human fertility data of any new peptide: in Phase 2 randomized trials it triggered egg maturation in IVF with a **45% live-birth rate and zero moderate or severe ovarian hyperstimulation syndrome (OHSS)** — a real safety advance over hCG triggers — but it remains investigational, unapproved, non-compoundable in the U.S., and short-half-life.[1](https://peptidevox.com/#r1)[2](https://peptidevox.com/#r2) Set expectations accordingly: **no** over-the-counter research peptide — not BPC-157, not the longevity/bioregulator peptides — has human evidence for treating infertility.[7](https://peptidevox.com/#r7)

## How do these peptides work on the reproductive axis?

Reproduction is governed by the **hypothalamic-pituitary-gonadal (HPG) axis**, and each peptide drug here substitutes for one specific signal.[21](https://peptidevox.com/#r21) At the top of the cascade, **kisspeptin** (acting via the KISS1R/GPR54 receptor) is the master switch that tells GnRH neurons to fire; people with inactivating mutations in kisspeptin signaling are infertile, which is why it became a drug target at all.[7](https://peptidevox.com/#r7) The hypothalamic signal itself is **GnRH (gonadorelin)**, released in pulses that drive the pituitary to secrete LH and FSH — replacing absent GnRH with a pulsatile pump is the most physiological way to restart the axis when the defect is hypothalamic.[17](https://peptidevox.com/#r17)

The pituitary outputs are **FSH and LH (the gonadotropins)**: FSH drives follicle growth (eggs) and Sertoli-cell support of sperm production, while LH drives ovulation and luteinization in women and Leydig-cell testosterone in men, which in turn fuels spermatogenesis.[8](https://peptidevox.com/#r8) Finally, **hCG** binds the same LH receptor as LH but has a far longer half-life (about 30-plus hours versus LH's roughly 30 minutes), so a single injection produces a sustained LH-like signal — which is why it is used as the ovulation and oocyte-maturation trigger in women and as LH replacement in men.[9](https://peptidevox.com/#r9) The functional-medicine caveat: these peptides *replace signals, they do not create gametes*. They cannot fix age-related egg quality, primary ovarian insufficiency, or non-obstructive azoospermia from primary testicular failure. The full literature on the HPG axis is catalogued in the NIH's [StatPearls physiology reference](https://www.ncbi.nlm.nih.gov/books/NBK558992/), which is worth reading before interpreting any fertility-hormone claim.[21](https://peptidevox.com/#r21)

## What does the human evidence show, ranked?

Ranked strictly by human fertility-outcome evidence, hCG and the gonadotropins lead, gonadorelin and kisspeptin follow in specific niches, and the research-chemical peptides bring up the rear with nothing.

  Fertility peptides by evidence strength

    PeptideBest human evidenceGrade

    hCGFDA-approved trigger; 5,610-cycle IUI cohort (higher live birth); induces spermatogenesis in male HHA
    Gonadotropins (FSH/LH)Multiple RCTs/meta-analyses for IVF stimulation; FSH+hCG for male spermatogenesisA
    Gonadorelin (pulsatile)Meta-analysis (~420 men) — earlier spermatogenesis than gonadotropins in CHHB
    Kisspeptin-54Phase 2 IVF trigger — 45% live birth, zero moderate/severe OHSS (investigational)B
    BPC-157 / TB-500 / GHK-Cu / epitalonNone — no human fertility-outcome trialsC-D

On the female side, hCG triggering rests on decades of assisted-reproduction practice: in a large retrospective cohort of 5,610 first natural-cycle donor-sperm IUI cycles, an hCG-triggered group had significantly higher clinical pregnancy (27.4% vs 22.7%) and live-birth (24.5% vs 20.1%) rates than spontaneous-LH-surge cycles.[9](https://peptidevox.com/#r9) Gonadotropins are the standard for controlled ovarian stimulation, with one meta-analysis finding hMG associated with a roughly 4% higher live-birth rate than recombinant FSH after long GnRH-agonist down-regulation.[13](https://peptidevox.com/#r13)[14](https://peptidevox.com/#r14) On the male side, combined hCG plus FSH achieves complete spermatogenesis in roughly 70-90% of men with hypogonadotropic hypogonadism, and pulsatile GnRH achieved earlier spermatogenesis than combined gonadotropins across roughly 420 men in a meta-analysis — with 17 of 28 (60.7%) previously gonadotropin-failed men producing sperm after switching.[12](https://peptidevox.com/#r12)[16](https://peptidevox.com/#r16)[18](https://peptidevox.com/#r18)

Kisspeptin is the frontier. In 60 high-OHSS-risk women, kisspeptin-54 triggered oocyte maturation in 95% (57/60), with clinical pregnancy 53% and live birth 45% per transfer — and critically no moderate, severe, or critical OHSS and no kisspeptin-related adverse events.[1](https://peptidevox.com/#r1) A dose-optimization RCT showed a second dose further improved maturation.[3](https://peptidevox.com/#r3) In men, KP-10 reliably raises LH and testosterone and serum kisspeptin correlates with sperm concentration as a possible biomarker, but no controlled trial shows kisspeptin *treats* male infertility — the male data are mechanistic, observational, and biomarker-level.[4](https://peptidevox.com/#r4)[5](https://peptidevox.com/#r5)[6](https://peptidevox.com/#r6)

The single most important men's-fertility point
Exogenous testosterone (TRT) and anabolic steroids **suppress** the HPG axis and shut down sperm production — TRT is effectively a contraceptive. Retrospective real-world data show hCG can restore spermatogenesis in men whose sperm production was suppressed by non-prescribed androgens; the evidence-based path is to stop or modify testosterone under a specialist and restart the axis with hCG, often with added FSH.[10](https://peptidevox.com/#r10)[11](https://peptidevox.com/#r11)

## What does the evidence NOT support?

No research-chemical peptide treats infertility. BPC-157, TB-500/thymosin beta-4, GHK-Cu, epitalon, MOTS-c, and the bioregulator and longevity peptides have **no human fertility-outcome trials** — claims that they improve egg quality or boost sperm are extrapolation or marketing, graded C-D at best.[7](https://peptidevox.com/#r7) Two more common confusions: online “gonadorelin for fertility” (single-shot, non-pulsatile) is *not* the validated pump-delivered pulsatile GnRH protocol, and kisspeptin-10 vials are not a home IVF trigger — the human trigger evidence is for kisspeptin-54 under monitoring.[17](https://peptidevox.com/#r17)[22](https://peptidevox.com/#r22) And none of these peptides reverse primary gamete failure.[8](https://peptidevox.com/#r8)

## What are the safety, contraindications and legal realities?

In women, OHSS is the defining risk — hCG and gonadotropin stimulation can cause ovarian over-response with fluid shifts and, rarely, life-threatening complications, which is precisely why GnRH-agonist and (investigationally) kisspeptin triggers were developed for high-risk patients; multiple pregnancy is the other major risk of ovulation induction.[20](https://peptidevox.com/#r20)[13](https://peptidevox.com/#r13) These are monitored, specialist-administered therapies, not lifestyle injectables: gonadotropin and hCG cycles require ultrasound and hormone monitoring, and pulsatile GnRH requires a pump and titration.[17](https://peptidevox.com/#r17)

On regulation (2026): hCG and gonadotropins are FDA-approved for the fertility indications above; gonadorelin is FDA-approved as **Factrel** (a diagnostic), with no actively marketed U.S. fertility/pump product; and kisspeptin is investigational, not approved, with the FDA's Pharmacy Compounding Advisory Committee having recommended against adding kisspeptin-10 to the 503A compounding list.[19](https://peptidevox.com/#r19)[22](https://peptidevox.com/#r22) In sport, WADA 2026 prohibits hCG and LH in males at all times, GnRH/gonadorelin and its agonist analogues in males, and kisspeptin and its analogues in males (S2.2.1); FSH is not similarly listed for males. Athletes seeking fertility treatment should obtain a Therapeutic Use Exemption.[23](https://peptidevox.com/#r23)[24](https://peptidevox.com/#r24)

**Bottom line.** The legitimate peptide story in fertility is the prescription reproductive-hormone story — hCG and the gonadotropins first, pulsatile gonadorelin in the hypothalamic niche — plus one investigational frontier in kisspeptin. There is no over-the-counter shortcut. From a root-cause lens, the highest-yield move before any injectable is diagnostic: identify *why* ovulation or spermatogenesis is failing and correct that, because these hormones work only when the rest of the axis and the gametes are viable.[8](https://peptidevox.com/#r8) Regulatory and anti-doping facts here are current as of June 2026 and should be re-verified against the primary sources.

---
Source: https://peptidevox.com/sexual-hormonal-health/peptides-for-fertility
Index: https://peptidevox.com/llms.txt · Full text: https://peptidevox.com/llms-full.txt